First Trade Ltd

First Trade Limited

After 20 years of providing proprietary, revolutionary ingredients and technology to top luxury skincare, pharmaceutical, and clinical brands around the world, co-founders Dr. Terry James and Jamie O’Banion decided to bring their breakthrough technology direct to consumers and founded Beauty Bioscience in 2010.
With a history of discovering next generation technology, such as pioneering the development of peptides in the 90s, both founders saw an opportunity after developing what they believed to be the next breakthrough in skincare. That breakthrough came in the form of a unique, proprietary GDR retinol molecule housed in a patent-pending delivery system called Titration Therapy®. Instead of selling this technology to one of the large cosmetic houses, as in times past, they launched the next generation of skincare with a product called RetinoSyn-45. As the brand continues to grow, Dr. James and Jamie have strategically brought only the most advanced, curated technology to the marketplace.
The centre piece of the Beauty Bioscience collection is the breakthrough concept of Titration Therapy showcased in RetinoSyn-45, a three phase treatment that titrates concentrations of a patent-pending Retinol Complex and Growth Factor Stimulant from low to high over a 45-day period. By starting at lower concentrations of powerful active ingredients and carefully increasing concentrations of actives, the traditional side effects associated with highly active retinol products are mitigated and maximum results are achieved. The skin is able to absorb levels that never would have been possible without titration and ultimately achieve dramatic visible anti-aging benefit. As a result, RetinoSyn-45 has finally harnessed the power of retinol for mass use while achieving clinical data the skincare industry has never before seen.
Promotional articles design and manufacture to customer specification